Breast Cancer Clinical Trial
Official title:
A Randomized Controlled Trial of Outpatient Geriatric Evaluation and Management Among Older Patients With Breast and Colon Cancer
RATIONALE: Gathering health information from older patients undergoing chemotherapy may help
doctors plan better treatment and improve the quality of life for these patients.
PURPOSE: This randomized clinical trial is studying how well an outpatient health care
program works for older patients receiving chemotherapy for newly diagnosed breast cancer or
colon cancer.
OBJECTIVES:
Primary
- Determine the effect of a 1-year geriatric evaluation and management (GEM) program on
adherence to adjuvant chemotherapy (defined as tolerance and timely completion of
planned dose) in patients with newly diagnosed breast or colon cancer.
Secondary
- Evaluate the effect of a 1-year GEM program on the health-related quality of life and
functional, cognitive, and mental status of these patients.
- Evaluate the effect of a 1-year GEM program on 3-year disease-free survival of these
patients.
- Compare the number of emergency room visits, acute hospitalizations, and associated
Medicare costs within the first 12 months following randomization to a GEM program vs
no program.
OUTLINE: Patients are stratified according to tumor site (breast vs colon). Patients are
randomized to 1 of 2 arms.
- Arm I (intervention): Patients complete health-related quality-of-life (QOL) and
comprehensive geriatric assessment questionnaires at baseline, within 30 days after
chemotherapy or at 6 months, and then at 12-13 months to assess functional status
(i.e., activities of daily living), comorbidity (i.e., medical problems), medications,
mood and memory, nutrition, and social support from family members and friends.
Patients receive a home visit from a social worker and visit the Senior Adult Oncology
clinic within 1 month after the first course of chemotherapy. The clinic staff develops
an individualized care plan for the patient and communicates the results of the
assessment questionnaires and their recommendations (e.g., medication and/or specialty
referrals) to the patient's primary care provider and oncologist. The staff meets
weekly to monitor and update the patient care plan. Patients are followed in the Senior
Adult Oncology clinic at least every 3 months for 1 year. Follow-up telephone calls and
in-home visits are also conducted as needed. Patients are also assessed prior to each
course of chemotherapy for toxicities related to the chemotherapy.
- Arm II (control): Patients complete a health-related QOL questionnaire at baseline,
within 30 days after chemotherapy or at 6 months, and then at 12-13 months. Patients
receive oncology and primary care by their usual health care providers.
After completion of the study intervention, patients' medical charts are reviewed
periodically for up to 2 years.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |